Clinical case of effective treatment of gestational pemphigoid with intravenous immunoglobulins
DOI:
https://doi.org/10.15574/PP.2020.83.87Keywords:
pemphigoid, pregnancy, autoimmune disease, intravenous immunoglobulinAbstract
Gestational pemphigus — is a rare autoimmune condition that manifest during pregnancy. This pathology was described for the first time in 1827 by the Karl Martius, but until now remains insufficiently studied and as a result, difficulties arise in the differential diagnosis and treatment. Clinical manifestations of the disease characterized by the appearance of a polymorphic rash on the skin and mucous membranes. In patients with impaired immune tolerance pemphigus can be complicated by hyperactivation of the immune system. To date, pregnancy is not considered as a factor that can aggravate the course of pemphigus, since during pregnancy the disease can worsen, enter into complete remission, or remain unchanged. In the literature, there is information about the manifestation of pemphigus in puerperium after rapid decrease of corticosteroid hormones in serum. The clinical course of gestational pemphigus is variable and can lead to diagnostic failures. The diagnosis usually made according to the clinic, histopathology and laboratory findings.
In this case report we describe a case of diagnosis and treatment of gestational pemphigoid, refractory to corticosteroid therapy. Clinical improvement and recovery achieved after a course of high doses of intravenous immunoglobulins.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of these Institutes. The informed consent of the patient was obtained for conducting the studies.
References
Anheyer D, Frawley J, Koch AK, Lauche R, Langhorst J, Dobos G, Cramer H. (2017). Herbal Medicines for Gastrointestinal Disorders in Children and Adolescents: A Systematic Review. PEDIATRICS: 139 (6): e20170062. https://doi.org/10.1542/peds.2017-0062; PMid:28562281
Benninga MA, Nurko S, Faure C et al. (2016). Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 150 (2): 1443-1455. https://doi.org/10.1053/j.gastro.2016.02.016; PMid:27144631
Camilleri M, Park S-Y, Scarpato E, Staiano A. (2017, February). Exploring Hypotheses and Rationale for Causes of Infantile Colic. Neurogastroenterol Motil. 29 (2): 10. https://doi.org/10.1111/nmo.12943; PMid:27647578 PMCid:PMC5276723
Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Troncone R et al. (2008). Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Digestive And Liver Disease. 40 (7): 547-553. https://doi.org/10.1016/j.dld.2008.01.017; PMid:18358796
Chien-Heng Lin, Hsiu-Chuan Yang, Chien-Sheng Cheng, Chin-En Yen et al. (2015). Effects of infant massage on jaundiced neonates undergoing phototherapy. Italian J Pediatr. 41 (94): 2-6. https://doi.org/10.1186/s13052-015-0202-y; PMid:26607061 PMCid:PMC4659198
Harb Tracy, Matsuyama Misa, David Michael et al. (2016). Infant Colic What works: A Systematic Review of Interventions for Breast-fed Infants. Journal of Pediatric Gastroenterology and Nutrition. 62 (5): 668-686. https://doi.org/10.1097/MPG.0000000000001075; PMid:26655941
Hassan Salehipoor, Behzad Afzali, Rahim Akrami, Fereshteh Ghorat, Zahra Niktabe, Mohammad Sahebkar. (2019). Effect of Topical Chamomile Oil (Matricaria chamomile L.) as a Supplementary Method on Colic Symptoms in Infants: A Randomized Placebo-controlled Clinical Trial. Iran J Neonatol. 10 (1): 15-19. doi: 10.22038/ijn.2019.32270.1448.
Hastroenterolohiia ditei rannoho viku. Za red. OH Shadrina, OM Mukvich. (2010). Dovidnyk likaria «Dytiachyi hastroenteroloh». L: TOV «Doktor Media». Seriia «Zdorov'ia Ukrainy»: 216.1. Antonette T. Dulay MD. (2019). Main Line Health System. Last full review/revision 2019. URL: https://www.msdmanuals.com/en-sg/professional/gynecology-and-obstetrics/abnormalities-of-pregnancy/cervical-insufficiency.
Blak M, Makay M, Braude P, Von Dzhounz S, Margesson L. Kozhnyie bolezni v akusherskoy i ginekologicheskoy praktike. Pod red VN Prilepskoy i EV Lipovoy. (2008). Moskva: Geotar-Media: 260.
Daniel Y, Shenhav M, Botchan A et al. (1995). Pregnancy associated with pemphigus. Br J Obstet Gynecol. 102: 667-669. https://doi.org/10.1111/j.1471-0528.1995.tb11410.x; PMid:7654649
Fainaru O et al. (2000). Pemphigus vulgaris in pregnancy: a case report and review of literature. Human reproduction. 15 (5): 1195-1197. https://doi.org/10.1093/humrep/15.5.1195; PMid:10783377
Gan DCC, Welsh B, Webster M. (2012). Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine. Australasian journal of dermatology. 53 (1): 66-69. https://doi.org/10.1111/j.1440-0960.2011.00854.x; PMid:22309336
Goldberg NS, DeFeo C, Kirshenbaum N. (1993). Pemphigus vulgaris and pregnancy: risk factors and recommendations. Journal of the American Academy of Dermatology. 28 (5): 877-879. https://doi.org/10.1016/0190-9622(93)70123-B
Gushi M et al. (2008). Neonatal pemphigus vulgaris. The Journal of dermatology. 35 (8): 529-535. https://doi.org/10.1111/j.1346-8138.2008.00515.x; PMid:18789074
Hallaji Z et al. (2017). Pemphigoid gestationis: clinical and histologic features of twenty-three patients. International Journal of Women's Dermatology. 3 (2): 86. https://doi.org/10.1016/j.ijwd.2016.11.004; PMid:28560301 PMCid:PMC5440447
Hertl M et al. (2006). T cell control in autoimmune bullous skin disorders. The Journal of clinical investigation. 116 (5): 1159-1166. https://doi.org/10.1172/JCI28547; PMid:16670756 PMCid:PMC1451217
Intong LR, Murrell DF. (2011). Pemphigoid gestationis: pathogenesis and clinical features. Dermatologic clinics. 29 (3): 447. https://doi.org/10.1016/j.det.2011.03.002; PMid:21605810
Intong LR, Murrell DF. (2011). Pemphigoid gestationis: pathogenesis and clinical features. Dermatologic clinics. 29 (3): 447. https://doi.org/10.1016/j.det.2011.03.002; PMid:21605810
Joly P et al. (1997). Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus. Journal of investigative dermatology. 108 (4): 469-475. https://doi.org/10.1111/1523-1747.ep12289720; PMid:9077476
Kalayciyan A et al. (2002). A retrospective analysis of patients with pemphigus vulgaris associated with pregnancy. British Journal of Dermatology. 147 (2): 396-396. https://doi.org/10.1046/j.1365-2133.2002.48299.x; PMid:12174129
Kaplan RP, Callen JP. (2983). Pemphigus associated diseases and induced pemphigus. Clinics in dermatology. 1 (2): 42-71. https://doi.org/10.1016/0738-081X(83)90022-6
Kardos M et al. (2009). Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes. Obstetrical&gynecological survey. 64 (11): 739-749. https://doi.org/10.1097/OGX.0b013e3181bea089; PMid:19849866
Kelsey W Salzberg, Melanie J Gero, Bruce D Ragsdale, MD. (2014, Oct). Pemphigus Vulgaris in Pregnancy. Cutis. 94 (4): 206-209.
Kitajima Y, Aoyama Y. (2007). A perspective of pemphigus from bedside and laboratory-bench. Clinical Reviews in Allergy & Immunology. 33 (1-2): 57-66. https://doi.org/10.1007/s12016-007-0036-5; PMid:18094947
Kneisel A, Hertl M. (2011). Autoimmune bullous skin diseases. Part 1: clinical manifestations. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 9 (10): 844-857. https://doi.org/10.1111/j.1610-0387.2011.07793.x; PMid:21955378
Meurer M. (2009). Pemphigus diseases in children and adolescents. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 60 (3): 208. https://doi.org/10.1007/s00105-009-1733-1; PMid:19242669
Nguyen T, Alraqum E, Ahmed AR. (2015). Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis. International Immunopharmacology. 26 (1): 1-3. https://doi.org/10.1016/j.intimp.2015.02.038; PMid:25765353
Parker VJ, Douglas AJ. (2010). Stress in early pregnancy: maternal neuro-endocrine-immune responses and effects. Journal of reproductive immunology. 85 (1): 86-92. https://doi.org/10.1016/j.jri.2009.10.011; PMid:20079933
Piontek JO et al. (2000). Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange. British Journal of Dermatology. 143 (2): 455-456. https://doi.org/10.1046/j.1365-2133.2000.03686.x; PMid:10951169
Ruach M et al. (1995). Pemphigus vulgaris and pregnancy. Obstetrical&Gynecological Survey. 50 (10): 755-760. https://doi.org/10.1097/00006254-199510000-00023; PMid:8524526
Ruocco E et al. (2013). Pemphigus: associations and management guidelines: facts and controversies. Clinics in dermatology. 31 (4): 382-390. https://doi.org/10.1016/j.clindermatol.2013.01.005; PMid:23806155
Schmidt E, Zillikens D. (2013). Pemphigoid diseases. The Lancet. 381 (9863): 320-332. https://doi.org/10.1016/S0140-6736(12)61140-4
Schmutz JL. (2003). Dermatological diseases influenced by pregnancy. Presse medicale (Paris, France: 1983). 32 (38): 1809-1812.
Tani N et al. (2015). Clinical and immunological profiles of 25 patients with pemphigoid gestationis. British Journal of Dermatology. 172 (1): 120-129. https://doi.org/10.1111/bjd.13374; PMid:25154546
Torgerson RR et al. (2006). Oral and vulvar changes in pregnancy. Clinics in dermatology. 24 (2): 122-132. https://doi.org/10.1016/j.clindermatol.2005.10.004; PMid:16487887
Yang A, Uhlenhake E, Murrell DF. (2018). Pemphigoid gestationis and intravenous immunoglobulin therapy. Int J Womens Dermatol. 4 (3): 166-169. Published 2018 May 3. https://doi.org/10.1016/j.ijwd.2018.03.007; PMid:30175219 PMCid:PMC6116823
Downloads
Published
Issue
Section
License
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.